GeoVax Labs Filing Becomes Effective

Ticker: GOVX · Form: EFFECT · Filed: Apr 20, 2026 · CIK: 0000832489

Sentiment: neutral

Topics: regulatory-filing, effectiveness, sec-filing

Related Tickers: GOVX

TL;DR

GeoVax filing EFFECT, approved 4/17/26. Big news for $GOVX?

AI Summary

GeoVax Labs, Inc. filed an EFFECT form on April 20, 2026, indicating the effectiveness of a filing related to Act 33, File No. 333-281973. The effectiveness date is April 17, 2026. The company's mailing and business address is 1955 Lake Park Drive, Suite 300, Smyrna, GA.

Why It Matters

This filing indicates a regulatory milestone for GeoVax Labs, Inc., potentially related to a securities offering or other corporate action that has now received SEC approval.

Risk Assessment

Risk Level: low — This is a routine regulatory filing indicating effectiveness, not a direct financial event.

Key Numbers

Key Players & Entities

FAQ

What specific action does the EFFECT filing relate to for GeoVax Labs, Inc.?

The filing is an 'EFFECT' form, which signifies the effectiveness of a registration statement or other filing with the SEC, but the specific underlying action is not detailed in this document.

When did the SEC filing for GeoVax Labs, Inc. become effective?

The filing became effective on April 17, 2026.

What is the CIK number for GeoVax Labs, Inc.?

The CIK number for GeoVax Labs, Inc. is 0000832489.

What is the business address of GeoVax Labs, Inc.?

The business address is 1955 Lake Park Drive, Suite 300, Smyrna, GA.

What is the File Number associated with this EFFECT filing?

The File Number is 333-281973.

Filing Details

This Form EFFECT (Form EFFECT) was filed with the SEC on April 20, 2026 regarding GeoVax Labs, Inc. (GOVX).

View full filing on EDGAR

View Full Filing

View this EFFECT filing on SEC EDGAR

View on Read The Filing